![]() |
市場調查報告書
商品編碼
2048254
疝氣修補網片市場-全球產業規模、佔有率、趨勢、機會和預測:按疝氣類型、網片類型、地區和競爭對手分類,2021-2031年Hernia Mesh Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia), By Mesh Type (Biologic Mesh, Synthetic Mesh), By Region & Competition, 2021-2031F |
||||||
全球疝氣修補網片(一種由合成或生物基材料製成的外科植入,用於加固疝氣修補術中脆弱的組織)市場預計將從 2025 年的 47.9 億美元大幅成長到 2031 年的 71.6 億美元,複合年成長率為 6.93%。
這一成長主要受全球疝氣發病率上升的驅動,而疝氣發病率上升通常與人口老化和肥胖率上升有關。此外,人們越來越傾向於選擇無張力修補術,以縮短患者復原時間。這些潛在因素持續推高了對可靠組織加固解決方案的需求,凸顯了此類器械的持續必要性。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 47.9億美元 |
| 市場規模:2031年 | 71.6億美元 |
| 複合年成長率:2026-2031年 | 6.93% |
| 成長最快的細分市場 | 複合網格 |
| 最大的市場 | 北美洲 |
然而,市場進展受到重大產品安全隱患的阻礙,尤其是術後併發症的風險,例如感染疾病、慢性疼痛和疝氣復發。這些問題往往導致代價高昂的訴訟和更嚴格的監管審查,阻礙醫療設備的廣泛應用。美國外科醫師學會2024年發布的一項臨床研究表明,腹壁重組的短期和長期復發率仍維持在1.4%至3%之間,凸顯了這些醫療設備持續面臨的表現挑戰。
推動全球疝氣修補網片市場變革的關鍵因素之一是微創和機器人輔助手術技術的日益普及。隨著外科醫生越來越傾向於採用能夠減輕患者負擔、加速康復的手術方式,市場對專為套管針插入和與機器人系統無縫整合而設計的專用網片植入的需求也日益成長。這些手術技術的進步要求器械既要具備強大的結構完整性,又要具備機器人精準定位所需的柔軟性。手術數量的成長充分體現了這一變化。例如,根據Intuitive Surgical公司2025年第二季報告,全球已完成約77.5萬例達文西機器人手術,年成長17%,凸顯了機器人手術在軟組織修復領域的應用日益廣泛。
此外,生物材料和複合網片材料的技術突破正在推動市場擴張,滿足了減少異物反應的臨床需求。製造商正陸續推出混合型和完全可吸收型解決方案,這些方案在提供臨時機械支撐的同時,還能促進組織自然再生,從而減少傳統永久性合成網片通常伴隨的長期併發症。 BD公司於2025年4月推出的Phasix ST臍疝氣修補片就是此類創新的一個例子,它是首款專為臍疝氣修補而設計的完全可吸收裝置。這些尖端材料的商業性成功顯而易見,TELA Bio公司2025年第三季財報顯示,其增強型組織基質產品組合的銷售額達到2,070萬美元,較去年同期成長9%。
全球疝氣修補網片市場擴張面臨的主要障礙之一是產品安全問題,尤其是術後併發症(如感染疾病和慢性疼痛)的風險。這些臨床問題往往會對患者造成嚴重後果,需要昂貴的修復手術和長期醫療照護。因此,製造商面臨巨大的法律責任和不斷增加的訴訟成本,導致原本可以投入研發的資金被挪用。此外,日益嚴格的審查也促使監管機構實施更嚴格的核准程序,從而延長了產品開發週期,並延緩了新技術的應用。
此外,不利事件的持續發生直接削弱了外科醫生和患者的信心,導致他們在複雜病例中不願採用基於網片的手術技術。根據美國外科醫師學會 (ACS) 2024 年的數據,腹壁重組短期和長期併發症發生率在 7% 到 10% 之間,凸顯了此類植入在臨床應用方面仍然存在的不確定性。這種不確定性不僅延緩了現有產品的推廣應用,也造成了謹慎的市場環境,安全問題優先於技術進步,最終限制了市場的整體成長。
門診手術中心(ASC)疝氣修補網片使用量的增加正在從根本上改變市場格局,其驅動力是向更具成本效益的門診醫療服務模式的更廣泛轉變。由於與傳統住院醫院相比,這些機構運作成本更低、手術流程更有效率,因此醫療服務提供者和保險公司越來越傾向於選擇這些機構進行常規疝氣修補術。麻醉技術的進步進一步推動了這一轉變,使得患者能夠更安全地當日出院。這種變化的規模在財務表現中顯而易見。例如,Surgery Partners, Inc. 在 2025 年 3 月報告稱,其全年收入將達到 31 億美元,成長 13.5%,而這一成長的主要驅動力是其短期住院手術中心網路內病例數量的增加。
同時,自固定和無縫線網片設計的創新使得無需使用縫合釘和縫合釘等穿透性固定裝置,從而推進了外科手術技術的發展。這些先進的植入利用微型抓握技術和黏合襯裡將網片牢固地固定在組織上,顯著降低了神經壓迫和慢性術後疼痛的風險,而這些風險通常與機械固定有關。此外,這些設計縮短了手術時間,在臨床安全性和手術效率方面均具有優勢。臨床數據也支持其有效性。發表於2025年2月《外科內視鏡》(Surgical Endoscopy)雜誌的一項題為「使用自固定網片進行腹腔鏡腹股溝疝氣修補術」的研究顯示,使用自固定網片治療的患者復發率僅為1.1%,證實了該裝置與傳統方法相比的可靠性。
The global market for hernia mesh devices, which are surgical implants made from synthetic or biologic materials used to reinforce weakened tissues during hernia repair, is projected to expand significantly, from USD 4.79 Billion in 2025 to USD 7.16 Billion by 2031, demonstrating a 6.93% compound annual growth rate. This growth is primarily fueled by the increasing worldwide incidence of hernias, often linked to an aging global population and rising obesity rates, coupled with the growing preference for tension-free repair techniques that shorten patient recovery periods. These fundamental factors generate a consistent demand for reliable tissue reinforcement solutions, underscoring the enduring necessity for these devices.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 4.79 Billion |
| Market Size 2031 | USD 7.16 Billion |
| CAGR 2026-2031 | 6.93% |
| Fastest Growing Segment | Synthetic Mesh |
| Largest Market | North America |
However, the market's progression is hampered by substantial product safety concerns, particularly the risks of post-surgical complications like infection, chronic pain, and hernia recurrence. Such issues frequently result in expensive litigation and heightened regulatory oversight, which could impede device adoption. Clinical research, as reported by the American College of Surgeons in 2024, indicates that short and long-term recurrence rates in abdominal wall reconstruction continue to range between 1.4% and 3%, underscoring the ongoing performance challenges faced by these devices.
Market Driver
A significant driver transforming the Global Hernia Mesh Devices Market is the growing embrace of minimally invasive and robotic-assisted surgical procedures. As surgeons increasingly favor techniques that lessen patient trauma and accelerate recovery, there is a heightened demand for specialized mesh implants engineered for trocar deployment and seamless integration with robotic systems. This surgical progression necessitates devices that offer both robust structural integrity and the pliability required for accurate, robotically guided placement. The magnitude of this shift is illustrated by procedural volumes; for instance, Intuitive Surgical's 'Quarterly Report' for Q2 2025 noted approximately 775,000 da Vinci procedures globally, marking a 17% year-over-year increase, which highlights the expanding use of robotic methods for soft tissue repairs.
Furthermore, technological breakthroughs in biologic and composite mesh materials are propelling market expansion by addressing clinical needs for reduced foreign body reactions. Manufacturers are progressively introducing hybrid and fully absorbable solutions that offer temporary mechanical support while fostering natural tissue regeneration, thereby reducing long-term complications typically associated with permanent synthetic meshes. An example of this innovation is BD's April 2025 launch of the Phasix ST Umbilical Hernia Patch, the first fully absorbable device specifically designed for umbilical hernia repair. The strong commercial success of these advanced materials is evident, as TELA Bio's 'Third Quarter 2025 Financial Results' reported that revenue for their reinforced tissue matrix portfolio reached $20.7 million, achieving 9% growth over the preceding year.
Market Challenge
A significant obstacle impeding the expansion of the Global Hernia Mesh Devices Market stems from product safety concerns, particularly the risks of post-surgical complications like infection and chronic pain. These clinical issues often lead to severe patient outcomes, requiring expensive corrective surgeries and prolonged medical care. Consequently, manufacturers encounter substantial legal liabilities and rising litigation costs, diverting financial resources that could otherwise be invested in research and development. This heightened scrutiny also prompts regulatory bodies to implement more stringent approval procedures, thereby prolonging product development timelines and delaying the introduction of new innovations.
Moreover, the ongoing occurrence of adverse events directly diminishes confidence among both surgeons and patients, fostering reluctance to adopt mesh-based procedures for intricate cases. Data from the American College of Surgeons in 2024 indicated that short and long-term wound complication rates in abdominal wall reconstruction ranged between 7% and 10%, highlighting the persistent clinical unpredictability linked to these implants. This uncertainty not only slows the adoption of current products but also cultivates a cautious market environment where safety concerns overshadow technological progress, ultimately limiting the overall market's growth trajectory.
Market Trends
The increasing use of hernia mesh in Ambulatory Surgical Centers (ASCs) is fundamentally transforming the market, driven by a broad shift towards cost-effective, outpatient healthcare delivery models. Both healthcare providers and payers are progressively favoring these facilities for routine hernia repairs due to their lower operational costs and more efficient procedural workflows compared to traditional inpatient hospitals. This transition is further supported by enhanced anesthetic methods that enable safe same-day patient discharge. The magnitude of this shift is demonstrated by financial results; for instance, Surgery Partners, Inc. reported a 13.5% increase in full-year revenues to $3.1 billion in March 2025, largely crediting this growth to higher case volumes within their network of short-stay surgical centers.
Simultaneously, innovations in self-fixating and sutureless mesh designs are evolving surgical techniques by removing the necessity for penetrating fixation devices like tacks and staples. These advanced implants utilize micro-grip technologies or adhesive backings to securely anchor the mesh to tissue, substantially mitigating the risk of nerve entrapment and chronic post-operative pain frequently linked to mechanical fixation. Moreover, these designs shorten operative times, providing benefits in both clinical safety and procedural efficiency. Clinical data validates this effectiveness; a February 2025 study in Surgical Endoscopy on 'Laparoscopic inguinal hernia repair with self-fixated meshes' showed that patients treated with self-gripping mesh had a low recurrence rate of 1.1%, confirming the device's reliability compared to conventional approaches.
Report Scope
In this report, the Global Hernia Mesh Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Hernia Mesh Devices Market.
Global Hernia Mesh Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: